Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 30, 2012	Apr. 01, 2011	Apr. 02, 2010
Cash Flows From Operating Activities:
Net income	$ 74,402	$ 74,664	$ 69,363
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	26,847	25,065	21,940
Amortization of intangible assets	8,930	6,378	5,121
Amortization of debt discount and issuance costs	10,289	9,447	8,852
Noncash compensation expense	7,302	10,227	12,772
Provision for doubtful accounts	2,858	1,741	3,795
(Benefit) provision for deferred income taxes	(1,284)	3,251	(8,264)
Provision for deferred compensation	1,165	1,423	1,530
(Gain) loss on sales of property and equipment	(102)	19	81
Gain on sale of available for sale securities	0	0	(3,635)
Changes in operating assets and liabilities, net of effects from business combinations:
Accounts receivable, net	85	(7,257)	221
Inventories	4,096	12,265	(9,718)
Prepaid expenses and other current assets	833	(6,433)	(5,710)
Other assets	(10,885)	(7,973)	(4,685)
Accounts payable	8,828	(8,153)	(5,129)
Accrued expenses and other liabilities	(5,080)	1,664	15,867
Net cash provided by operating activities	128,284	116,328	102,401
Cash Flows From Investing Activities:
Payments for business combinations, net of cash acquired	(65,131)	(65,934)	(14,802)
Capital expenditures	(23,918)	(18,227)	(25,923)
Payment for investment in variable interest entity, net of cash	0	(3,277)	0
Proceeds from sale of available for sale securities	0	0	10,681
Other investing activities	(163)	(668)	(541)
Net cash used in investing activities	(89,212)	(88,106)	(30,585)
Cash Flows From Financing Activities:
Proceeds from issuance of debt	250,000	0	0
Proceeds from borrowings on the revolving line of credit	405,056	106,400	5,350
Repayments on the revolving line of credit	(405,056)	(106,400)	(55,350)
Purchase and retirement of common stock	(140,439)	(54,761)	(57,176)
Payment of contingent consideration on business acquisitions	(9,500)	(862)	0
Payment of debt issuance costs	(6,467)	0	0
Excess tax benefits from stock-based compensation arrangements	2,057	3,187	2,516
Proceeds from exercise of stock options	1,383	2,079	4,489
Payments under capital lease obligations	(779)	(834)	(925)
Other financing activities	(1,523)	(434)	0
Net cash provided by (used in) financing activities	94,732	(51,625)	(101,096)
Net increase (decrease) in cash and cash equivalents	133,804	(23,403)	(29,280)
Cash and cash equivalents, beginning of period	29,348	52,751	82,031
Cash and cash equivalents, end of period	$ 163,152	$ 29,348	$ 52,751